Norfolk Southern Corporation vs Twist Bioscience Corp — how do they compare? Norfolk Southern Corporation trades at $334 (market cap $75.15B), while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). The key difference: Norfolk Southern Corporation is far larger — about 9.7× Twist Bioscience Corp's market cap, and Norfolk Southern Corporation pays a 1.61% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| NSC | TWST | |
|---|---|---|
Market Cap | $75.15B | $7.72B |
Sector | Technology | Health |
52-Week High | $350.66 | $124.88 |
52-Week Low | $272.35 | $24.16 |
Enterprise Value | $90.70B | $7.65B |
Dividend Yield | 1.61% | — |
Trailing returns across standard periods
Latest headlines on both assets
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →